Literature DB >> 476883

The effects of coronary artery disease on the ventricular fibrillation threshold in man.

L N Horowitz, J F Spear, M E Josephson, J A Kastor, E N Moore.   

Abstract

The ventricular fibrillation threshold (VFT) was measured in 28 patients at the time of cardiac surgery. The VFT was measured with a 100 Hz train of 24 rectangular pulses positioned across the ST segment and T wave. Current was applied to the epicardial surface of either ventricle with a bipolar electrode probe. In six patients, the normal right VFT was 24.3 +/- 5.2 mA, and in 10 patients the normal left VFT was 33.6 +/- mA (p less than 0.05). In 12 patients with greater than or equal to 75% obstruction of the left anterior descending coronary artery, the left VFT was 18.6 +/- 6.9 mA. This value was significantly less than the left VFT in patients without coronary artery disease (p less than 0.001). This study shows that the VFT can be measured in man and that coronary artery disease reduces this parameter.

Entities:  

Mesh:

Year:  1979        PMID: 476883     DOI: 10.1161/01.cir.60.4.792

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  4 in total

1.  The role of lipid peroxidation in pathogenesis of arrhythmias and prevention of cardiac fibrillation with antioxidants.

Authors:  F Z Meerson; L M Belkina; T G Sazontova; V A Saltykova
Journal:  Basic Res Cardiol       Date:  1987 Mar-Apr       Impact factor: 17.165

Review 2.  Cardiac and skeletal muscle effects of electrical weapons : A review of human and animal studies.

Authors:  Sebastian N Kunz; Hugh Calkins; Jiri Adamec; Mark W Kroll
Journal:  Forensic Sci Med Pathol       Date:  2018-06-28       Impact factor: 2.007

3.  Ventricular fibrillation: are swine a sensitive species?

Authors:  Gregory P Walcott; Mark W Kroll; Raymond E Ideker
Journal:  J Interv Card Electrophysiol       Date:  2015-01-16       Impact factor: 1.900

4.  Coronary artery disease, coronary revascularization, and outcomes in chronic advanced systolic heart failure.

Authors:  Mihai Gheorghiade; James D Flaherty; Gregg C Fonarow; Ravi V Desai; Richard Lee; David McGiffin; Thomas E Love; Inmaculada Aban; Eric J Eichhorn; Robert O Bonow; Ali Ahmed
Journal:  Int J Cardiol       Date:  2010-06-16       Impact factor: 4.164

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.